First Non-Drug Treatment Approved by FDA for Treating Children With ADHD
Talia Puzantian, PharmD, BCPP
Joshua Feder, MD
Drs. Puzantian and Feder have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Read More

Joshua Feder, MD
Joshua Feder, MD
Editor-in-Chief, The Carlat Child Psychiatry Report
Joshua Feder, MD
Editor-in-chief, CCPR
Dr. Feder has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747)



